NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures
NCT ID: NCT00969839
Last Updated: 2009-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
20 participants
INTERVENTIONAL
2009-09-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intramedullary Fixation of Humerus Fractures
NCT01017289
Operative Versus Nonoperative Treatment of Humeral Shaft Fractures: A Prospective Cohort Comparison Study
NCT01363518
Intramedullary Fixation of Humerus Fractures Without Intramedullary Reaming
NCT01087463
Affixus Natural Nail System Humeral Nail PMCF
NCT05019664
Humeral Compression/Distraction Device
NCT02861495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intramedullary Fixation System
Humeral fractures to be treated with the Intramedullary Fixation System
NovaLign Intramedullary Fixation System
Intramedullary fixation of broken humerus
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NovaLign Intramedullary Fixation System
Intramedullary fixation of broken humerus
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgical intervention can be performed within 14 days of injury (injury being Day 0 for this particular criteria)
* Fully functioning contralateral limb (e.g., hand, arm, shoulder)
* Age 18 years or older and skeletally mature
Exclusion Criteria
* Pathologic fracture (e.g., tumor involvement, osteomalacia, etc.; osteoporosis is not an exclusion)
* Evidence of neurologic injury in the index arm, including compartment syndrome or radial nerve palsy
* Additional upper body injuries (e.g., upper extremity, abdominal, thoracic, neck or head injury) that may affect or inhibit the evaluation of the index or contralateral arm, shoulder, elbow, etc or would not allow the patient to follow or comply with appropriate post-operative regimens
* Any previous bodily injury or surgery that may interfere with function or evaluation of index or contralateral arm, shoulder, elbow, etc.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NovaLign Orthopaedics, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NovaLign Orthopaedics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
B Crist, MD
Role: PRINCIPAL_INVESTIGATOR
University of Missouri-Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver Health Medical Center
Denver, Colorado, United States
University of Missouri - Columbia
Columbia, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
S Morgan, MD
Role: primary
A Baron
Role: backup
B Crist, MD
Role: primary
L Anderson, RN
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SP-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.